Post Cardiac Surgery Hemodynamics Diagnostic Device
Post Cardiac Surgery Hemodynamics Diagnostic Device
批准号:
10256581
负责人:
Anil Kottam
金额:
$25.65万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2022-07-31
关键词:
Acute Kidney FailureAgeAged, 80 and overAmericanAnimalsAntihypertensive AgentsBlood VolumeBypassCardiacCardiac Surgery proceduresCardiac TamponadeCardiac VolumeCardiovascular systemCaregiversCathetersChestClinicalClinical ResearchClinical TrialsConnective TissueCoronaryDangerousnessDetectionDevelopmentDevicesDiagnosisDiagnosticDialysis procedureDifferential DiagnosisDiscriminationDoctor of PhilosophyDrainage procedureElectrodesEngineeringEnsureEpicardiumEvaluation StudiesFamily suidaeHealthHeartHeart failureHospitalsHumanHypotensionHypovolemiaImplantIncidenceInfectionIntensive Care UnitsKidneyKnowledgeLeadLiquid substanceLow Cardiac OutputMeasurementMeasuresMedicalModificationMonitorMorbidity - disease rateMorphologyMyocardiumOctogenarianOperative Surgical ProceduresOutcomePatientsPerformancePericardial body locationPhasePopulationPostoperative PeriodPrincipal InvestigatorProceduresPulmonary artery structureRecoveryResearchResearch PersonnelResourcesRiskSafetySmall Business Innovation Research GrantSpecialistSternotomySurfaceSystemSystems DevelopmentTestingTimeTubeUnited States National Institutes of HealthVascular blood supplyWorkage relatedaging populationclinical efficacyclinically actionabledesignempoweredflexibilityheart damagehemodynamicshigh riskhospital readmissionhuman old age (65+)implantationimprovedmanufacturabilitymortalitynew technologynovelolder patientpericardial sacpre-clinicalpreclinical studypressurepreventprophylacticprototyperesponsetouchscreenvalve replacementverification and validation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Coronary arterial bypass graft (CABG) and valve replacements are open-heart surgeries that
are performed on 400,000 Americans each year. The average age of cardiac surgery patients is
early 60s, with 52% over the age of 65, and 8% over the age of 80. Octogenarians are
increasingly being referred for cardiac surgery, because the aging population is increasing
rapidly, and they still benefit enough from CABG to improve long term survival despite higher
risk. However, they also have longer post-operative stays in ICU and hospital, and higher rates
of ICU readmission. Unexplained hypotension in this population is of particular concern during
recovery, because although pressures are routinely measured continuously, discrimination
between proper treatment courses requires an additional measure of heart volumes. The
previous standard for volume management (a partially implanted Pulmonary Artery Catheter, or
PAC) is now considered too risky for prophylactic implantation due to the added risks of another
invasive procedure, infection, lack of evidence that it changes outcomes. Without information on
volume status, multiple day recovery with only minimal bedside hospital staff present makes the
proper diagnosis and rapid treatment of unexplained hypotension tricky. In the older cardiac
surgery patient, age-related modifications in cardiac morphology result in decreased contractile
reserve, reduced compliance, and blunted inotropic response. This leads to hypotensive
situations where the proper diagnosis of cardiac damage or weakness can be confused with low
volume status (hypovolemia) and reduced vessel compliance requiring exploratory surgery. All
unsure staff in this situation prudently call for an echo, the resident fellow, or other available
cardiovascular specialists to infer what the volume is while the patient’s hypotensive state
persists, increasing risk. BSM proposes to modify the ubiquitously placed pericardial drain to
discriminate among these two states without a PAC, by using a novel, clinically-validated
volume measurement, empowering staff to take the proper clinical course of action quickly to
stabilize elderly patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post Cardiac Surgery Hemodynamics Diagnostic Device
-
批准号:10453483
-
项目类别:
-
资助金额:$74.03万
-
财政年份:2022
-
负责人:Anil Kottam
-
依托单位:
Post Cardiac Surgery Hemodynamics Diagnostic Device
-
批准号:10707900
-
项目类别:
-
资助金额:$95.89万
-
财政年份:2022
-
负责人:Anil Kottam
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: